Cargando…
Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies
Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy in women of reproductive age. This condition is characterized by hyperandrogenism and either oligo- or anovulation. PCOS patients often present comorbidities such as obesity, insulin resistance, impaired glucose metabolism, dyslip...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532286/ https://www.ncbi.nlm.nih.gov/pubmed/37762856 http://dx.doi.org/10.3390/jcm12185915 |